Exodus Movement, Inc. Announces Uplist to NYSE American Exchange 6-05-2024, 19:15

Zoom debuts new agentic AI skills and agents for Zoom AI Companion 17-03-2025, 20:00

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00